P.006 Alzheimer’s disease CSF biomarker testing and its impacts on clinical management: findings from the IMPACT-AD BC study

Background: Within the IMPACT-AD BC study, we sought to address the gap in knowledge around how the use of Alzheimer’s disease (AD) CSF biomarker testing impacts clinical management. Methods: IMPACT-AD BC (NCT05002699, impactAD.org) is an observational, longitudinal study examining the role of AD CS...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Canadian journal of neurological sciences 2023-06, Vol.50 (s2), p.S58-S59
Hauptverfasser:	Patel, KJ, Best, JR, Yang, D, Chambers, C, Lee, PE, Henri-Bhargava, A, Funnell, CR, Foti, DJ, Feldman, HH, Pettersen, JA, Nygaard, HB, Hsiung, GR, DeMarco, ML
Format:	Artikel
Sprache:	eng
Schlagworte:	Abstracts Adult Neurology (CNS/CSC) Alzheimer's disease Biomarkers Counseling Decision making Dementia Dementia and Cognitive Disorders Diagnostic tests Poster Presentations
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!